New Report on Toxic Posterior Segment Syndrome Following Dropless Cataract Surgery with Compounded Triamcinolone-Moxifloxacin
In 2017, an unexpected cluster of patients in the Dallas area who had recently undergone dropless cataract surgery (DLCS) developed toxic posterior segment syndrome (TPSS), a rare, non-infectious inflammatory condition affecting the
read more
Dr. Abbey Reports on Latest Study Evaluating DME Outcomes After Switching from Faricimab-svoa to High-dose Aflibercept
In the latest issue of Ophthalmic Surgery, Lasers & Imaging Retina, Texas Retina’s Ashkan M. Abbey, MD, co-authored a retrospective study evaluating the effectiveness of high-dose aflibercept 8 mg (Eylea HD) in
read more
Recent Study Examined the Cytopathology and Prognostic Accuracy of the 15-GEP/PRAME Assay for Uveal Melanoma Metastasis
As part of the Collaborative Ocular Oncology Group (COOG), Texas Retina’s Timothy Fuller, MD, recently participated in a multi-center clinical research cohort study to determine if the results of an additional cell examination
read more
Texas Retina Opens Eight New Clinical Trials
At Texas Retina, we are committed to conducting ongoing research that could improve care for our patients — a value instilled by the pioneering physicians who founded our practice more than 50
read more
Dr. Abbey Presents ARCHER II Clinical Trial Data at The Retina Society Annual Scientific Meeting
Texas Retina’s Ashkan Abbey, MD, presented baseline characteristics of participants in the Phase 3 ARCHER II clinical trial for geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD) at the 59th
read more
A New Way to Explore Career Opportunities at Texas Retina
Texas Retina has launched a new Careers page to make it easier to learn about career opportunities and current openings within our organization. For more than six decades, Texas Retina has brought
read more
Frequently Asked Questions About Eye Injections
For many retinal diseases like age-related macular degeneration, diabetic retinopathy, retinal vein occlusion and uveitis, an eye injection (also called an intravitreal injection) is the only way we can deliver potentially sight-saving medication where it is needed
read more Dr. Abbey Receives 2026 Achievement Award from the American Academy of Ophthalmology
Texas Retina’s Ashkan M. Abbey, MD, has earned the 2026 Achievement Award from the American Academy of Ophthalmology (AAO) in recognition of his contributions to the Academy, its scientific and educational programs,
read more
Eye Injury Prevention Month: Four Tips to Protect Your Eyes
Thousands of eye accidents happen each day, and according to the American Academy of Ophthalmology (AAO), nearly half of all eye injuries occur in the home. Did you know that wearing protective
read more
When Should You See a Retina Specialist?
Your ophthalmologist or optometrist can monitor your vision, prescribe glasses and contact lenses, and diagnose, treat and prevent a number of eye diseases. However, for some eye conditions, your eye doctor may
read more